Loading...

Azelis Group NV

AZLGFPNK
Basic Materials
Chemicals - Specialty
$15.95
$-0.03(-0.19%)

Azelis Group NV (AZLGF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Azelis Group NV (AZLGF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
2.07%
2.07%
Operating Income Growth
4.57%
4.57%
Net Income Growth
1.68%
1.68%
Operating Cash Flow Growth
-24.15%
24.15%
Operating Margin
9.11%
9.11%
Gross Margin
24.33%
24.33%
Net Profit Margin
4.26%
4.26%
ROE
6.49%
6.49%
ROIC
7.81%
7.81%

Azelis Group NV (AZLGF) Income Statement & Financial Overview

Review Azelis Group NV AZLGF income statement with detailed quarterly and annual figures.

MetricQ4 2024Q2 2024Q4 2023Q3 2023
Revenue$2.07B$2.15B$2.01B$1.006B
Cost of Revenue$1.80B$1.63B$1.76B$777.44M
Gross Profit$273.32M$513.63M$249.38M$228.06M
Gross Profit Ratio$0.13$0.24$0.12$0.23
R&D Expenses$0.00$0.00$717000.00$717000.00
SG&A Expenses$111.70M$253.96M$95.92M$124.90M
Operating Expenses$111.70M$298.95M$95.92M$157.11M
Total Costs & Expenses-$1.91B$1.93B$1.86B$934.55M
Interest Income$5.54M$18.56M$8.45M$24.21M
Interest Expense$71.48M$135.81M$70.70M$0.00
Depreciation & Amortization$58.79M$56.13M$52.67M$13.79M
EBITDA$244.07M$272.51M$206.12M$96.06M
EBITDA Ratio$0.12$0.13$0.10$0.10
Operating Income$161.62M$214.68M$153.46M$82.27M
Operating Income Ratio$0.08$0.10$0.08$0.08
Other Income/Expenses (Net)-$47.82M-$72.40M-$106.72M-$35.53M
Income Before Tax$113.80M$142.29M$93.38M$46.74M
Income Before Tax Ratio$0.06$0.07$0.05$0.05
Income Tax Expense$24.48M$42.16M$13.35M$6.67M
Net Income$85.87M$94.82M$74.25M$37.12M
Net Income Ratio$0.04$0.04$0.04$0.04
EPS$0.35$0.39$0.30$0.15
Diluted EPS$0.35$0.39$0.30$0.15
Weighted Avg Shares Outstanding$243.77M$243.56M$243.77M$244.31M
Weighted Avg Shares Outstanding (Diluted)$244.02M$243.56M$246.08M$244.22M

Over the last four quarters, Azelis Group NV achieved steady financial progress, growing revenue from $1.006B in Q3 2023 to $2.07B in Q4 2024. Gross profit stayed firm with margins at 13% in Q4 2024 versus 23% in Q3 2023. Operating income totaled $161.62M in Q4 2024, maintaining a 8% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $244.07M. Net income dropped to $85.87M, with EPS at $0.35. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;